JP2021534182A5 - - Google Patents
Info
- Publication number
- JP2021534182A5 JP2021534182A5 JP2021507889A JP2021507889A JP2021534182A5 JP 2021534182 A5 JP2021534182 A5 JP 2021534182A5 JP 2021507889 A JP2021507889 A JP 2021507889A JP 2021507889 A JP2021507889 A JP 2021507889A JP 2021534182 A5 JP2021534182 A5 JP 2021534182A5
- Authority
- JP
- Japan
- Prior art keywords
- self
- composition according
- derived
- antigen
- immunogenic composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862719219P | 2018-08-17 | 2018-08-17 | |
| US62/719,219 | 2018-08-17 | ||
| PCT/EP2019/072052 WO2020035609A2 (en) | 2018-08-17 | 2019-08-16 | Immunogenic compositions and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021534182A JP2021534182A (ja) | 2021-12-09 |
| JP2021534182A5 true JP2021534182A5 (https=) | 2022-08-22 |
Family
ID=67766133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021507889A Pending JP2021534182A (ja) | 2018-08-17 | 2019-08-16 | 免疫原性組成物及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US12083174B2 (https=) |
| EP (1) | EP3836963A2 (https=) |
| JP (1) | JP2021534182A (https=) |
| CN (1) | CN113164584A (https=) |
| AU (1) | AU2019321186B2 (https=) |
| CA (1) | CA3109165A1 (https=) |
| WO (1) | WO2020035609A2 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019121513A1 (en) | 2017-12-18 | 2019-06-27 | Intervet International B.V. | Swine influenza a virus vaccine |
| AU2021236068A1 (en) | 2020-03-09 | 2022-10-06 | Arcturus Therapeutics, Inc. | Compositions and methods for inducing immune responses |
| IL296752A (en) * | 2020-04-03 | 2022-11-01 | Gritstone Bio Inc | Infectious disease antigens and vaccines |
| EP4153223A1 (en) * | 2020-05-20 | 2023-03-29 | Flagship Pioneering Innovations VI, LLC | Immunogenic compositions and uses thereof |
| BR112022025678A2 (pt) * | 2020-06-19 | 2023-01-17 | Intervet Int Bv | Vacina contra o vírus da influenza a suína compreendendo duas partículas de replicon de rna distintas |
| EP4196128A4 (en) | 2020-08-14 | 2024-06-12 | Arcturus Therapeutics, Inc. | METHOD FOR FREEZE DILIZATION OF LIPID NANOPARTICLES |
| EP4228658A4 (en) | 2020-10-14 | 2025-02-19 | George Mason Research Foundation, Inc. | IONIZABLE LIPIDS AND METHODS FOR THE PRODUCTION AND USE THEREOF |
| KR20230120646A (ko) * | 2020-12-02 | 2023-08-17 | 세퀴러스 인코포레이티드 | 멀티시스트론성 rna 백신 및 이의 용도 |
| KR20240009952A (ko) * | 2021-05-19 | 2024-01-23 | 다이이찌 산쿄 가부시키가이샤 | 인플루엔자 바이러스 핵산 지질 입자 백신 |
| CA3239025A1 (en) * | 2021-11-29 | 2023-06-01 | Nathaniel Stephen Wang | Methods of generating self-replicating rna molecules |
| WO2023213378A1 (en) * | 2022-05-02 | 2023-11-09 | BioNTech SE | Replicon compositions and methods of using same for the treatment of diseases |
| US20240009296A1 (en) * | 2022-07-10 | 2024-01-11 | Pfizer Inc. | Self-amplifying rna encoding an influenza virus antigen |
| KR20250140103A (ko) * | 2023-02-09 | 2025-09-24 | 화이자 인코포레이티드 | 핵산 및 이의 용도 |
| WO2024254461A2 (en) * | 2023-06-07 | 2024-12-12 | Nutech Ventures | Methods and compositions for vaccine development and delivery |
| EP4727579A1 (en) * | 2023-06-19 | 2026-04-22 | Seqirus Inc. | Multivalent subtype influenza vaccine |
| CN117205309B (zh) * | 2023-11-07 | 2024-02-02 | 今发制药(南京)有限公司 | 一种流感免疫原组合物和制备方法及其用途 |
| WO2025210141A1 (en) * | 2024-04-05 | 2025-10-09 | Boehringer Ingelheim Vetmedica Gmbh | Delivery system useful for topical administration of rna |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| US5132418A (en) | 1980-02-29 | 1992-07-21 | University Patents, Inc. | Process for preparing polynucleotides |
| US4500707A (en) | 1980-02-29 | 1985-02-19 | University Patents, Inc. | Nucleosides useful in the preparation of polynucleotides |
| US4973679A (en) | 1981-03-27 | 1990-11-27 | University Patents, Inc. | Process for oligonucleo tide synthesis using phosphormidite intermediates |
| US4668777A (en) | 1981-03-27 | 1987-05-26 | University Patents, Inc. | Phosphoramidite nucleoside compounds |
| US4373071A (en) | 1981-04-30 | 1983-02-08 | City Of Hope Research Institute | Solid-phase synthesis of polynucleotides |
| US5153319A (en) | 1986-03-31 | 1992-10-06 | University Patents, Inc. | Process for preparing polynucleotides |
| US5047524A (en) | 1988-12-21 | 1991-09-10 | Applied Biosystems, Inc. | Automated system for polynucleotide synthesis and purification |
| US5262530A (en) | 1988-12-21 | 1993-11-16 | Applied Biosystems, Inc. | Automated system for polynucleotide synthesis and purification |
| US5700642A (en) | 1995-05-22 | 1997-12-23 | Sri International | Oligonucleotide sizing using immobilized cleavable primers |
| CN1989250B (zh) | 2004-05-18 | 2013-11-20 | 阿尔法瓦克斯公司 | Tc-83衍生的甲病毒属载体、颗粒和方法 |
| CA2766907A1 (en) * | 2009-07-06 | 2011-01-13 | Novartis Ag | Self replicating rna molecules and uses thereof |
| CA3009891C (en) | 2009-12-23 | 2020-09-15 | Novartis Ag | Lipids, lipid compositions, and methods of using them |
| MX342608B (es) | 2010-07-06 | 2016-10-06 | Novartis Ag * | Particulas de suministro similares a viriones para moleculas de arn de autorreplicacion. |
| US9192661B2 (en) | 2010-07-06 | 2015-11-24 | Novartis Ag | Delivery of self-replicating RNA using biodegradable polymer particles |
| NZ606591A (en) | 2010-07-06 | 2015-02-27 | Novartis Ag | Cationic oil-in-water emulsions |
| ES2557382T3 (es) | 2010-07-06 | 2016-01-25 | Glaxosmithkline Biologicals Sa | Liposomas con lípidos que tienen un valor de pKa ventajoso para el suministro de ARN |
| LT4226941T (lt) | 2010-08-31 | 2025-01-10 | Glaxosmithkline Biologicals Sa | Pegilintos liposomos, skirtos imunogeną koduojančios rnr pristatymui |
| MX2013002332A (es) | 2010-08-31 | 2013-03-18 | Novartis Ag | Lipidos apropiados para suministro liposomal del arn que codifica la proteina. |
| SI4043040T1 (sl) | 2010-08-31 | 2023-04-28 | Glaxosmithkline Biologicals Sa | Mali liposomi za dostavo imunogen-kodirajoče RNA |
| EP4115875A1 (en) | 2011-07-06 | 2023-01-11 | GlaxoSmithKline Biologicals S.A. | Liposomes having useful n:p ratio for delivery of rna molecules |
| CA2841047A1 (en) | 2011-07-06 | 2013-01-10 | Novartis Ag | Immunogenic compositions and uses thereof |
| JP6059220B2 (ja) * | 2011-07-06 | 2017-01-18 | ノバルティス アーゲー | 核酸を含む水中油型エマルジョン |
| MX350258B (es) | 2011-07-06 | 2017-08-31 | Novartis Ag | Emulsiones cationicas de aceite en agua. |
| MX366055B (es) | 2011-08-31 | 2019-06-26 | Novartis Ag | Liposomas pegilados para admistracion de acido ribonucleico (arn) que codifica para inmunogeno. |
| RU2014118727A (ru) * | 2011-10-11 | 2015-11-20 | Новартис Аг | Рекомбинантные самореплицирующиеся полицистронные молекулы рнк |
| CN109045294A (zh) * | 2013-01-10 | 2018-12-21 | 思齐乐 | 流感病毒免疫原性组合物及其应用 |
| CN107879960B (zh) | 2013-03-08 | 2021-06-22 | 诺华股份有限公司 | 用于传递活性成分的脂质和脂质组合物 |
| EP3083556B1 (en) | 2013-12-19 | 2019-12-25 | Novartis AG | Lipids and lipid compositions for the delivery of active agents |
| US10426737B2 (en) | 2013-12-19 | 2019-10-01 | Novartis Ag | Lipids and lipid compositions for the delivery of active agents |
| US10125092B2 (en) | 2014-09-05 | 2018-11-13 | Novartis Ag | Lipids and lipid compositions for the delivery of active agents |
| BR112018014109A2 (en) * | 2016-01-11 | 2018-12-11 | Verndari, Inc. | microneedle compositions and methods of using them |
| CN106822887A (zh) | 2017-01-26 | 2017-06-13 | 中国科学院微生物研究所 | 一种流感病毒四价亚单位疫苗及其应用 |
-
2019
- 2019-08-16 US US17/268,647 patent/US12083174B2/en active Active
- 2019-08-16 AU AU2019321186A patent/AU2019321186B2/en active Active
- 2019-08-16 WO PCT/EP2019/072052 patent/WO2020035609A2/en not_active Ceased
- 2019-08-16 EP EP19758926.0A patent/EP3836963A2/en active Pending
- 2019-08-16 CN CN201980068212.4A patent/CN113164584A/zh active Pending
- 2019-08-16 JP JP2021507889A patent/JP2021534182A/ja active Pending
- 2019-08-16 CA CA3109165A patent/CA3109165A1/en active Pending
-
2024
- 2024-08-06 US US18/795,336 patent/US20250064916A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021534182A5 (https=) | ||
| Park et al. | mRNA vaccines for COVID-19: what, why and how | |
| Lu et al. | The potential neurological effect of the COVID‐19 vaccines: a review | |
| JP2014520807A5 (https=) | ||
| JP2014522842A5 (https=) | ||
| Mehraeen et al. | Vaccines for COVID-19: a systematic review of feasibility and effectiveness | |
| JP2014520806A5 (https=) | ||
| JP2023551982A5 (https=) | ||
| Simnani et al. | COVID-19 phase 4 vaccine candidates, effectiveness on SARS-CoV-2 variants, neutralizing antibody, rare side effects, traditional and nano-based vaccine platforms: a review | |
| Lee et al. | Influenza viruses: innate immunity and mRNA vaccines | |
| HRP20230226T1 (hr) | Pegilirani liposomi za isporuku rna koja kodira imunogen | |
| JP2016539946A5 (https=) | ||
| JP2019526580A5 (https=) | ||
| JP2007211026A5 (https=) | ||
| JP2018514565A5 (https=) | ||
| Li et al. | Clinical cardiovascular emergencies and the cellular basis of COVID-19 vaccination: from dream to reality? | |
| JP7403733B2 (ja) | インフルエンザｈａスプリットワクチンの製造方法 | |
| JP2024537250A (ja) | インフルエンザワクチン | |
| JP2015524802A5 (https=) | ||
| JP2014519817A5 (https=) | ||
| US20250339511A1 (en) | Nucleic acid vaccine against monkeypox virus and use thereof | |
| Rando et al. | The coming of age of nucleic acid vaccines during COVID-19 | |
| Ftouh et al. | Contribution of nanotechnologies to vaccine development and drug delivery against respiratory viruses | |
| CN112294954B (zh) | 一种禽用佐剂组合物及其制备方法和应用 | |
| CN101843901A (zh) | 以纳米乳剂为佐剂的流感病毒疫苗及其制备方法 |